The timing of this FDA public meeting might just be prescient
https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/public-meeting-fda-rare-disease-day-2023-02272023
meeting agenda here https://www.fda.gov/media/165133/download
Michelle Campbell is from the Office of Neuroscience too so I would assume she has been involved in the NDA process
and Catherine Park who organises Rare Disease Day conferences and is moderating an open public comment period. no doubt someone from the Int Rett Syndrome foundation is clued into this.
Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-72
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.11 |
Change
-0.090(0.63%) |
Mkt cap ! $1.750B | |||
| Open | High | Low | Value | Volume |
| $14.23 | $14.71 | $14.01 | $6.213M | 438.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7700 | $14.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.16 | 3278 | 1 |
View Market Depth
| Last trade - 16.16pm 30/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |